The Inhibitory Effect of Intravesical Fisetin against Bladder Cancer by Induction of p53 and Down-Regulation of NF-kappa B Pathways in a Rat Bladder Carcinogenesis Model
Author:
Affiliation:
1. Department of Urology; Shaanxi Provincial People's Hospital; The Third Affiliated Hospital of the Medical College of Xi'an Jiaotong University; Xi'an China
2. Institute of Urology; The Second Hospital of Lanzhou University; Lanzhou China
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12229/fullpdf
Reference54 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Strategies to improve drug delivery in bladder cancer therapy;Wirth;Expert Opin Drug Deliv,2009
3. Immunotherapy for superficial bladder cancer;Schenk-Braat;Cancer Immunol Immunother,2005
4. Side effects of perioperative intravesical treatment and treatment strategies for these side effects;Griffin;Urol Clin North Am,2013
5. Adverse events after intravesical therapy: are we always ready to recognize and prevent them?;Fiorito;Urologia,2013
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MISP-mediated enhancement of pancreatic cancer growth through the Wnt/β-catenin signaling pathway is suppressed by Fisetin;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-09
2. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis;Nutrients;2024-04-18
3. Binding patterns of derivatives of fisetin and chrysin to the enzyme complex cyclin-dependent kinase 6/cyclin D;Theoretical Chemistry Accounts;2023-10-19
4. Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent;European Journal of Medical Research;2023-08-25
5. Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies;Global Medical Genetics;2023-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3